Speaker illustration

Mrs Marianne Lachaux

INSERM U1096, Rouen (France)

Acute imeglimin treatment improves metabolic syndrome-related cardiac and coronary endothelial dysfunction in the zucker fa/fa rat

Event: ESC Congress 2018

Topic: Antidiabetic Pharmacotherapy

Session: Best Posters in cardiovascular remodelling


Short- and long-term imeglimin treatment reduces metabolic syndrome-related diabetic cardiomyopathy

Event: ESC Congress 2017

Topic: Diastolic dysfunction

Session: Chronic heart failure (CHF)


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb